Evaluating laser photobiomodulation for chemotherapy-induced peripheral neuropathy: a randomised phase II trial.
Christina TengSam EggerPrunella L BlinmanJanette L VardyPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
PBM may offer clinically meaningful symptom benefit in cancer survivors with established CIPN with improvement potentially continuing beyond completion of the intervention. A larger study is warranted to evaluate this further.